DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$56.1B
1-Year Return
19.33%
This Quarter Return
-4.5%
1 Year Return
+19.33%
3 Year Return
+93.16%
5 Year Return
+155.59%
10 Year Return
+349.91%
AUM
$33.8B
AUM Growth
-$562M
(-1.6%)
Cap. Flow
+$876M
Cap. Flow
% of AUM
2.59%
Top 10 Holdings %
Top 10 Hldgs %
23.33%
Holding
1,460
New
97
Increased
616
Reduced
423
Closed
88
Top Buys
| 1 |
NVIDIA
NVDA
|
+$117M |
| 2 |
L3Harris
LHX
|
+$81.2M |
| 3 |
PNC Financial Services
PNC
|
+$70.4M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$69.8M |
| 5 |
Johnson & Johnson
JNJ
|
+$68.1M |
Top Sells
| 1 |
Lam Research
LRCX
|
+$71M |
| 2 |
Linde
LIN
|
+$51.8M |
| 3 |
Amazon
AMZN
|
+$42.6M |
| 4 |
Meta Platforms (Facebook)
META
|
+$37M |
| 5 |
Encompass Health
EHC
|
+$35.8M |
Sector Composition
| 1 | Technology | 24.13% |
| 2 | Healthcare | 19.65% |
| 3 | Financials | 10.78% |
| 4 | Industrials | 9.28% |
| 5 | Consumer Discretionary | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
676
Jones Lang LaSalle
JLL
$14.6B
| $2.33M | 0.01% |
15,738
-39,104
| -71% | -$5.78M |
|
677
Qualys
QLYS
$4.75B
| $2.33M | 0.01% |
16,557
| – | – |
|
678
Idacorp
IDA
$6.76B
| $2.31M | 0.01% |
23,091
-2,271
| -9% | -$227K |
|
679
Arrowhead Research
ARWR
$3.99B
| $2.3M | 0.01% |
70,000
-10,050
| -13% | -$331K |
|
680
Corpay
CPAY
$21.5B
| $2.3M | 0.01% |
12,737
+1,519
| +14% | +$274K |
|
681
Molson Coors Class B
TAP
$9.7B
| $2.27M | 0.01% |
47,563
+5,744
| +14% | +$274K |
|
682
Medical Properties Trust
MPW
$2.77B
| $2.25M | 0.01% |
191,749
-4,358
| -2% | -$51.2K |
|
683
Wabtec
WAB
$32.4B
| $2.25M | 0.01% |
27,596
+2,522
| +10% | +$206K |
|
684
BJs Wholesale Club
BJ
$12.8B
| $2.24M | 0.01% |
30,256
-1,471
| -5% | -$109K |
|
685
Campbell Soup
CPB
$9.98B
| $2.22M | 0.01% |
47,783
+1,773
| +4% | +$82.5K |
|
686
Open Text
OTEX
$8.93B
| $2.22M | 0.01% |
82,220
+7,509
| +10% | +$202K |
|
|
RVNC
687
DELISTED
Revance Therapeutics, Inc.
RVNC
| $2.21M | 0.01% |
86,100
| – | – |
|
688
Concentrix
CNXC
$3.25B
| $2.2M | 0.01% |
19,533
-1,732
| -8% | -$195K |
|
689
Amicus Therapeutics
FOLD
$2.45B
| $2.2M | 0.01% |
217,700
| – | – |
|
690
Universal Display
OLED
$6.52B
| $2.19M | 0.01% |
22,900
-15,610
| -41% | -$1.49M |
|
691
Intellia Therapeutics
NTLA
$1.21B
| $2.18M | 0.01% |
40,000
+7,000
| +21% | +$381K |
|
692
Pentair
PNR
$17.9B
| $2.17M | 0.01% |
53,835
-31,839
| -37% | -$1.29M |
|
693
Hasbro
HAS
$10.9B
| $2.15M | 0.01% |
31,893
-11,038
| -26% | -$743K |
|
694
Insmed
INSM
$30.8B
| $2.14M | 0.01% |
98,600
| – | – |
|
695
Tapestry
TPR
$21.9B
| $2.13M | 0.01% |
73,998
+37,050
| +100% | +$1.07M |
|
696
Apollo Global Management
APO
$76.4B
| $2.13M | 0.01% |
45,270
-11,421
| -20% | -$537K |
|
697
Under Armour
UAA
$2.14B
| $2.13M | 0.01% |
+301,850
| New | +$2.13M |
|
698
Krystal Biotech
KRYS
$3.98B
| $2.11M | 0.01% |
30,300
| – | – |
|
699
Revvity
RVTY
$9.58B
| $2.07M | 0.01% |
16,647
+1,309
| +9% | +$162K |
|
700
Thomson Reuters
TRI
$76.8B
| $2.07M | 0.01% |
18,997
+664
| +4% | +$72.2K |
|